2021 Conference on Retroviruses and Opportunistic Infections*

Emerging HIV treatment options were at the forefront of CROI 2021. Here are my key takeaways from some of the most intriguing presentations.

Daniel R. Kuritzkes, MD Released: April 6, 2021

Highly anticipated data on long-acting PrEP options in development were presented at CROI 2021. Here are my interpretations of these data and considerations for future implementation.

Monica Gandhi, MD, MPH Released: April 8, 2021

Hear insights from Chloe Orkin, MBChB, FRCP, MD, on exciting new HIV data reported at the virtual CROI 2021, including new findings on HIV PrEP, HIV and COVID-19, ART in pregnancy and the postpartum period, as well as on the comparative efficacy of various ARV regimens.

Chloe Orkin, MBChB, FRCP, MD Released: March 18, 2021

In this downloadable slideset, CCO’s expert faculty members summarize key studies from this important annual conference, including new data on the following hot topics: HIV PrEP strategies; ART in pregnancy, the postpartum period, children and adolescents; racial disparities in COVID-19 outcomes among PWH; HIV and coinfections/comorbidities; and current and investigational ART.

Princy N. Kumar, MD, FIDSA, MACP Daniel R. Kuritzkes, MD Chloe Orkin, MBChB, FRCP, MD Released: March 30, 2021

Watch an on-demand Webcast from a live Webinar in which CCO’s expert faculty, Dr. Chloe Orkin, presents insights on some of the most clinically relevant new data presented at CROI 2021, including results from studies on HIV PrEP strategies, COVID-19 outcomes among PWH, ART during pregnancy/postpartum period, long-term use of current ART, and novel ART strategies in late-phase development.

Chloe Orkin, MBChB, FRCP, MD Released: March 26, 2021

Watch an on-demand Webcast from a live Webinar in which CCO’s expert faculty, Dr. Daniel Kuritzkes, presents insights on some of the most clinically relevant new data presented at CROI 2021, including results from studies on HIV PrEP strategies, COVID-19 outcomes among PWH, ART during pregnancy/postpartum period, long-term use of current ART, and novel ART strategies in late-phase development.

Daniel R. Kuritzkes, MD Released: March 26, 2021

Watch an on-demand Webcast from a live Webinar in which CCO’s expert faculty, Dr. Princy Kumar, presents insights on some of the most clinically relevant new data presented at CROI 2021, including results from studies on HIV PrEP strategies, COVID-19 outcomes among PWH, ART during pregnancy/postpartum period, long-term use of current ART, and novel ART strategies in late-phase development.

Princy N. Kumar, MD, FIDSA, MACP Released: March 26, 2021

Data presented at CROI 2021 show that the COVID-19 pandemic has disrupted health systems around the world, affecting diagnosis and treatment of HIV and other diseases, especially in low- and middle-income countries.

Dr. Zhao Yan Released: April 19, 2021

My take on data from several Kenyan studies presented at CROI 2021, including analyses of STI incidence among girls and young women and investigations into factors associated with and strategies for promoting improved PrEP uptake.

Nelly Mugo, MBChB, MMed, MPH Released: April 15, 2021

CROI 2021 provided more data on ARV-associated weight gain and longer-term data on injectable ART. Here are my key takeaways for healthcare professionals.

Don Smith, MD Released: April 20, 2021

Data on long-acting ART continued to dominate the presentations at CROI 2021. Here are my thoughts on the practicalities of potentially integrating these new drugs into my practice in Canada.

Darrell H. S. Tan, MD, FRCPC, PhD Released: April 1, 2021

People who inject drugs are at high risk for acquiring HIV infection and often have only limited engagement with HIV services. Although I provide HIV care in Eastern Europe, in this commentary, I share my thoughts on new data reported at CROI 2021 from studies conducted in India evaluating factors associated with HIV service engagement and the effects of the COVID-19 pandemic on PWID in the hopes that lessons learned in other regions can be applied to Eastern Europe and similar geographic areas that are grappling with high HIV transmission rates among PWID.

Alexander Panteleev, MD Released: June 24, 2021

My picks for interesting HIV treatment data presented at CROI 2021 include 2 studies performed in Spain, one comparing the efficacy of fixed-dose boosted PI combination ART vs second-generation integrase inhibitors and one investigating treatment options for newly diagnosed patients with advanced HIV.

José R. Arribas, MD Released: April 1, 2021

My pick for data presented at CROI 2021 is a study comparing post-ART weight gain in people with HIV in Latin America vs Latinx people with HIV in the United States and Canada.

Pedro Cahn, MD, PhD Released: April 5, 2021

在这份可下载的多页幻灯片中，CCO 的专家级教师总结了这次重要年度会议的关键研究成果，包括关于以下热点问题的新数据：HIV PrEP 策略；孕期、产后、儿童和青少年的 ART 治疗；PWH 群体中感染新冠病毒的种族差异；HIV 和合并感染/合并症，以及当前和研究性的 ART。

Princy N. Kumar, MD, FIDSA, MACP Daniel R. Kuritzkes, MD Chloe Orkin, MBChB, FRCP, MD Released: April 9, 2021

Neste conjunto de diapositivos descarregáveis, os membros peritos do corpo docente da CCO sintetizam estudos principais desta importante conferência anual, incluindo novos dados sobre os seguintes temas em destaque: Estratégias de PrEP do VIH; ART na gravidez, o período pós-parto, crianças e adolescentes; disparidades raciais nos resultados da COVID-19 entre PWH; VIH e coinfeções/comorbidades; e ART atual e de investigação.

Princy N. Kumar, MD, FIDSA, MACP Daniel R. Kuritzkes, MD Chloe Orkin, MBChB, FRCP, MD Released: April 9, 2021

En este conjunto de dispositivas descargables, el panel de expertos de CCO ofrece un resumen de los estudios clave de esta importante conferencia anual, incluidos datos de los siguientes temas de actualidad: estrategias PrEP para el VIH; TAR durante el embarazo, periodo posparto, niños y adolescentes; diferencias raciales en los resultados de la COVID-19 entre las PCV; VIH y coinfecciones/comorbilidades y TAR actuales y en investigación.

Princy N. Kumar, MD, FIDSA, MACP Daniel R. Kuritzkes, MD Chloe Orkin, MBChB, FRCP, MD Released: April 9, 2021